US Stock MarketDetailed Quotes

ABUS Arbutus Biopharma

Watchlist
  • 3.290
  • -0.010-0.30%
Close Feb 14 16:00 ET
  • 3.210
  • -0.080-2.43%
Post 20:01 ET
623.43MMarket Cap-7.65P/E (TTM)

About Arbutus Biopharma Company

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Company Profile

SymbolABUS
Company NameArbutus Biopharma
Listing DateJul 20, 2007
Founded2005
CEOMr. Michael J. McElhaugh
MarketNASDAQ
Employees73
Fiscal Year Ends12-31
Address701 Veterans Circle
CityWarminster
ProvincePennsylvania
CountryUnited States of America
Zip Code18974
Phone1-267-469-0914

Company Executives

  • Name
  • Position
  • Salary
  • Michael J. McElhaugh
  • Director, Chief Executive Officer and Interim President
  • 1.62M
  • David C. Hastings
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Karen Sims
  • Chief Medical Officer
  • --
  • Dr. Michael J. Sofia,PhD
  • Chief Scientific Officer
  • 1.61M
  • J. Christopher Naftzger
  • General Counsel, Chief Compliance Officer and Secretary
  • --
  • Dr. Frank M. Torti, M.D.
  • Chairman of the Board
  • 187.99K
  • Richard C. Henriques, M.B.A.
  • Independent Director
  • 174.24K
  • Keith Manchester, M.D.
  • Independent Director
  • 156.74K
  • Dr. Melissa V. Rewolinski, PhD
  • Independent Director
  • 212.09K
  • Daniel D. Burgess
  • Independent Director
  • 161.74K
  • James R. Meyers
  • Independent Director
  • 176.74K

Trending Stocks

Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More